Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study
2017 ◽
Vol 37
(6)
◽
pp. 865-873
◽
Keyword(s):
2009 ◽
Vol 69
(7)
◽
pp. 1269-1274
◽
2019 ◽
Vol 15
(1)
◽
pp. 3-20
2019 ◽
Vol Publish Ahead of Print
◽